Alexander Ernst, MD
Dermatology · Taylor, MINPI 1376923193
Payments from drug & device makers
Across 305 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$859
- Sanofi$764
- Johnson & Johnson$696
- Novartis$603
- LEO Pharma Inc.$464
- Regeneron Healthcare Solutions, Inc.$329
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,78896%
- Education$2514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $859 |
| Sanofi | 29 | $764 |
| Johnson & Johnson | 33 | $696 |
| Novartis | 46 | $603 |
| LEO Pharma Inc. | 33 | $464 |
| Regeneron Healthcare Solutions, Inc. | 12 | $329 |
| Incyte Corporation | 12 | $247 |
| GSK | 2 | $220 |
| Galderma Laboratories, L.p. | 22 | $216 |
| UCB, Inc. | 7 | $155 |
| Lilly USA, LLC | 8 | $143 |
| Dermavant Sciences, Inc. | 7 | $138 |
| Genmab U.S., Inc. | 1 | $132 |
| Arcutis Biotherapeutics, Inc. | 6 | $110 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Pfizer | 5 | $92 |
| Sun Pharmaceutical Industries Inc. | 5 | $91 |
| Merck | 5 | $87 |
| Boehringer Ingelheim | 3 | $76 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Amgen | 3 | $43 |
| Exact Sciences | 2 | $40 |
| Abiomed | 2 | $39 |
| Organon | 2 | $39 |
| Cipher Pharmaceuticals US LLC | 1 | $37 |
| Journey Medical Corporation | 1 | $24 |
| Novo Nordisk | 1 | $24 |
| Almirall LLC | 1 | $22 |
| Bayer | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Boston Scientific | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,039 in reported general payments places this provider in the 65th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 27 | $535,041 |
| Humira(Cf) PenAdalimumab | 20 | $267,536 |
| Dupixent PenDupilumab | 70 | $260,292 |
| Cosentyx Unoready PenSecukinumab | 18 | $196,829 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $80,383 |
| Clobetasol Propionate | 470 | $12,909 |
| Ketoconazole | 505 | $7,291 |
| Tacrolimus | 59 | $4,172 |
| Pimecrolimus | 28 | $4,104 |
| Clindamycin Phosphate | 92 | $3,776 |
| Fluorouracil | 50 | $3,514 |
| Metronidazole | 95 | $3,427 |
| Azelaic Acid | 21 | $3,005 |
| Betamethasone Dipropionate | 52 | $2,730 |
| Doxycycline Hyclate | 145 | $2,684 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Taylor
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
- Mio NakamuraAnn Arbor$1.4M
- George MurakawaTroy$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.